Pentwater Capital Management’s Axonics, Inc. Common Stock AXNX Stock Holding History

Pentwater Capital Management’s Portfolio AXNX Stock Details AXNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-157,800	Closed	-$11M	–	123
2024 Q3	$11M	Buy	157,800 +57,800	+58%	+$3.96M	0.11%	53
2024 Q2	$6.72M	Sell	100,000 -50,400	-34%	-$3.4M	0.09%	57
2024 Q1	$10.4M	Buy	+150,400	New	+$10.1M	0.11%	51
2020 Q1	–	Sell	-8,000	Closed	-$222K	–	163
2019 Q4	$222K	Buy	+8,000	New	+$191K	﹤0.01%	142

Other funds holding AXNX

TCA

Taconic Capital Advisors New York $212M AUM 100.15% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Pentwater Capital Management's AXNX Position: Q4 2024 in Review

Pentwater Capital Management sold out of Axonics, Inc. Common Stock (AXNX) in Q4 2024, closing a stake of 157,800 shares — an estimated $11M sold.

Pentwater Capital Management first reported a position in AXNX in Q4 2019 and held it in 4 quarters. The position peaked at $11M in Q3 2024. 2 funds tracked by Wall St. Rank hold AXNX as of Q4 2024.

Pentwater Capital Management reported no remaining Axonics, Inc. Common Stock position as of Q4 2024 after selling out during the quarter.
Pentwater Capital Management sold 157,800 Axonics, Inc. Common Stock shares in Q4 2024, an estimated $11M.
Pentwater Capital Management first reported a position in Axonics, Inc. Common Stock in Q4 2019 and held it in 4 quarters.
Pentwater Capital Management's Axonics, Inc. Common Stock position peaked at $11M in Q3 2024.
2 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q4 2024.

Based on Pentwater Capital Management's 13F filing for Q4 2024, filed 14 Feb 2025.